feed,title,long_url,short_url
Benzinga,AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting,https://benzinga.com/general/biotech/22/02/25747100/astrazenecas-enhertu-meets-primary-endpoint-in-her2-low-breast-cancer-setting,https://bit.ly/3v4tWBn
Benzinga,"FDA Rejects Zosano Pharma's Application For Zolmitriptan Microneedle System Again, Shares Plunge",https://benzinga.com/general/biotech/22/02/25745155/fda-rejects-zosano-pharmas-application-for-zolmitriptan-microneedle-system-again-shares-plunge,https://bit.ly/3LPslVP
